Clinical trials
Phase 1 Mesothelioma, Malignant trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 3 |
| Completed | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bayer | 1 |
| BerGenBio ASA | 1 |
| Ikena Oncology | 1 |
| Nurix Therapeutics, Inc. | 1 |
| Seagen Inc. | 1 |
| Verastem, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mesothelioma, Malignant | 6 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Melanoma | 2 |
| COVID-19 | 1 |
| Carcinoma, Ovarian Epithelial | 1 |
| Carcinoma, Transitional Cell | 1 |
| Colorectal Neoplasms | 1 |
| Glioblastoma | 1 |
| Hemangioendothelioma, Epithelioid | 1 |
| Leukemia, Myeloid, Acute | 1 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.